Results

Camp4 Therapeutics Corporation

12/10/2025 | Press release | Distributed by Public on 12/10/2025 09:40

American Epilepsy Society Annual Meeting: CMP-002: A Developmental Candidate Antisense Oligonucleotide Targeting a SYNGAP1 Regulatory RNA For The Potential Treatment of[...]

Camp4 Therapeutics Corporation published this content on December 10, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on December 10, 2025 at 15:40 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]